Allied Market Research

2026

Transarterial Chemoembolization Market

Transarterial Chemoembolization Market (2023-2032)

by Product Type (Chemotherapeutic Agents, Radio therapeutic Agents, Drug-eluting Particles), by Procedure Type (Conventional TACE, DEB-TACE), by Indication (Unresectable HCC, Early-Stage HCC) and, by End User (Hospitals, Clinics, Cancer Research Centers)

LS : Pharmaceuticals

Select an option
Author's: | Eswara Prasad
Publish Date: